Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-10-20

Clinical Trial Update: 0.005% Sodium Hypochlorite Final Rinse Solution in Atopic Dermatitis [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a 0.005% sodium hypochlorite final rinse solution for atopic dermatitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 0.005% Sodium Hypochlorite Final Rinse Solution (sodium hypochlorite final rinse solution)

Snippet

Sponsor: Makati Medical Center | Conditions: Atopic Dermatitis | Phase 1 | Status: WITHDRAWN